NEXGEL, Inc. (NXGLW) stock
NXGLWNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NXGL
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026Score 6/3072% below fair value
$0.01+0.00 (0.00%)
Close on Oct 30, 2026Market cap $34.21MP/E –Yield –
Nexgel free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Nexgel's free cash flow for the twelve months ending Dec 31, 2025 was -$1.38M. For fiscal 2025 it was -$1.38M. The highest annual figure on record is -$1.38M in fiscal 2025.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$1.38M | – |
| FY2024 | Dec 31, 2024 | -$4.31M | – |
| FY2023 | Dec 31, 2023 | -$3.93M | – |
| FY2022 | Dec 31, 2022 | -$3.09M | – |
| FY2021 | Dec 31, 2021 | -$3.02M | – |
| FY2020 | Dec 31, 2020 | -$2.11M | – |
| FY2019 | Dec 31, 2019 | -$1.81M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | -$513.00K | – |
| Q4 FY2025 | Dec 31, 2025 | $241.00K | – |
| Q3 FY2025 | Sep 30, 2025 | -$793.00K | – |
| Q4 FY2024 | Dec 31, 2024 | -$928.00K | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.23M | – |
| Q2 FY2024 | Jun 30, 2024 | -$909.00K | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.24M | – |
| Q4 FY2023 | Dec 31, 2023 | -$672.00K | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.08M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.38M | – |
| Q1 FY2023 | Mar 31, 2023 | -$797.00K | – |
| Q4 FY2022 | Dec 31, 2022 | -$657.00K | – |
| Q3 FY2022 | Sep 30, 2022 | -$905.00K | – |
| Q2 FY2022 | Jun 30, 2022 | -$729.00K | – |
| Q1 FY2022 | Mar 31, 2022 | -$797.00K | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.08M | – |
| Q3 FY2021 | Sep 30, 2021 | -$646.00K | – |
| Q2 FY2021 | Jun 30, 2021 | -$688.00K | – |
| Q1 FY2021 | Mar 31, 2021 | -$612.00K | – |
| Q4 FY2020 | Dec 31, 2020 | -$583.00K | – |
| Q3 FY2020 | Sep 30, 2020 | -$474.00K | – |
| Q2 FY2020 | Jun 30, 2020 | -$395.00K | – |
| Q1 FY2020 | Mar 31, 2020 | -$661.00K | – |
| Q4 FY2019 | Dec 31, 2019 | -$387.00K | – |
| Q3 FY2019 | Sep 30, 2019 | -$268.00K | – |